Jiangfeng You Selected Research

Vacuolar Proton-Translocating ATPases (V-Type ATPase)

1/2018	Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.
4/2015	LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity.
4/2014	Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
3/2014	[LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity].
3/2013	A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain.
7/2012	Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiangfeng You Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 10/2002
11	Neoplasm Metastasis (Metastasis) 04/2021 - 10/2002
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 12/2003
6	Carcinoma (Carcinomatosis) 01/2018 - 10/2002
2	Carcinogenesis 04/2021 - 03/2014
2	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2014
2	Adenocarcinoma 01/2021 - 11/2018
2	Lymphatic Metastasis 04/2014 - 03/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Adenosquamous Carcinoma 01/2021
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Hepatocellular Carcinoma (Hepatoma) 06/2013
1	Infections 06/2013
1	Virus Diseases (Viral Diseases) 06/2013
1	Chronic Hepatitis B 06/2013
1	Medulloblastoma 09/2007

Drug/Important Bio-Agent (IBA)

7	Adenosine Triphosphatases (ATPase)IBA 01/2018 - 12/2003
6	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2018 - 07/2012
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2002
4	Small Interfering RNA (siRNA)IBA 01/2018 - 07/2012
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2016
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2012
1	Serine (L-Serine)FDA Link 04/2021
1	CateninsIBA 04/2021
1	MucinsIBA 01/2021
1	PlatinumIBA 01/2021
1	LigandsIBA 11/2018
1	CaspasesIBA 07/2015
1	Biological ProductsIBA 07/2015
1	1,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA 04/2015
1	Tyrosine Kinase InhibitorsIBA 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	matrigelIBA 03/2014
1	AgarIBA 03/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2007
1	Complementary DNA (cDNA)IBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2015
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 11/2018
1	Liver Transplantation 06/2013